THOUGHT LEADERSHIP | REGULATORY COMPLIANCE | DECENTRALIZED TRIALS
Decentralized Trials and Regulatory Readiness: Navigating FDA, EMA, and Emerging Standards Decentralized clinical trials (DCTs) are no longer an experiment. They are the new operating
Decentralized Trials and Regulatory Readiness: Navigating FDA, EMA, and Emerging Standards Decentralized clinical trials (DCTs) are no longer an experiment. They are the new operating
Why Modern Clinical Research Blends Site-Based Rigor with Digital Flexibility Clinical trials are undergoing a structural transformation. What began as an emergency response during the COVID-19 pandemic
The pharmaceutical industry is undergoing a profound transformation. Drug pipelines are expanding. Regulatory expectations are increasing. Development timelines are shrinking. At the center of this
As pharmaceutical development grows more intricate, Chemistry, Manufacturing, and Controls (CMC) stands at the forefront of innovation, compliance, and efficiency. While traditional CMC principles remain vital, 2026
In the high-stakes world of regulatory affairs, the Chemistry, Manufacturing, and Controls (CMC) section of a New Drug Application (NDA) or Marketing Authorization Application (MAA)
Medical Digital Twins — When the Soul Meets the Body in Medicine For centuries, doctors have treated the human body by looking outward—at symptoms, scans,
Bridging the Gap: AI Tools That Reduce Sponsor–Site Friction The success of a clinical trial often hinges on sponsors and sites coordination. Three areas in
How Agentic AI is Shaping the Future of Clinical Trials The life sciences industry is at a turning point — and the most significant shift
AI in Patient Recruitment: Sponsor Roadmap for Faster, Smarter Studies Recruitment challenges are not new — but they’re getting more expensive. Industry data shows that